Song Jun attends int'l academic exchange meeting on COVID-19 treatment
The world is a community shared in the future. Only by strengthening international cooperation can we defeat the epidemic .
The China Association of Chinese Medicine (CACM) called a video international academic exchange meeting on COVID-19 treatment on April 6, 2020.
Over 70 heads of health science and technology organizations, medical experts and representatives of traditional Chinese medicine (TCM) enterprises from China, the U.S., the U.K., Germany, France and Spain attended the meeting.
Among the attendees were Song Jun, executive secretary of the China Association for Science and Technology (CAST), Tong Xiaolin, head of medical treatment, National Administration of Traditional Chinese Medicine and member of the Chinese Academy of Sciences (CAS), Zhu Hong, chief of the Economic and Commercial Counsellor's Office, Chinese Embassy in the U.S., Susan Lee, Maryland State Senator, Michael Nerlich, president of the German-Chinese Society of Medicine, and Wang Guochen, vice president and secretary general of CACM.
In his speech, Song extended high respect and sincere greetings to the frontline medics of epidemic control worldwide via participants of the meeting on behalf of CAST.
He noted that since the outbreak of the COVID-19 epidemic, under the leadership of Chinese President Xi Jinping, the Chinese government and people have given top priority to people's safety and health.
Through society-wide efforts, a joint prevention and control mechanism and science-based measures and acting in an open and transparent manner, China has achieved major phased results, Song said.
Especially, China gave full play to the unique advantages of TCM in treating COVID-19, including preventive treatment, diagnosis and treatment based on an overall analysis of the illness and the patient's conditions and multiple-target therapeutic intervention, and it formed a systematic treatment plan that featured TCM and a combination of TCM and Western medicine, Song told participants, applauding the plan as a successful practice in TCM inheritance and innovation.
Song stressed that countries around the world is a community of shared future and only by stepping up international cooperation can they foster greater synergy for defeating the epidemic and dealing with this major global challenge to public health security.
Tong Xiaolin gave a systematic introduction about TCM's participation in the treatment of COVID-19 and the results achieved in a report entitled "TCM's Perception and Treatment of COVID-19" at the meeting. Xia Wenguang, vice president of the Hubei Hospital of Integrated Traditional Chinese and Western Medicine and head of the hospital’s COVID-19 expert team, gave a report entitled “Rehabilitation Strategies for COVID-19 Patients -- Integration of TCM and Western Medicine” based on his diagnosis and treatment experiences in Wuhan, the epicenter of the epidemic. Andrew Schober, a critical care medicine specialist and assistant professor of the School of Medicine, University of California, San Francisco, Christoph Gutenbrunner, president of Global Rehabilitation Alliance and director of the Coordination Center of Rehabilitation Research, Hannover Medical School, Germany, and Li Yingrui, co-founder and chief scientist of iCarbonX, also gave thematic reports at the meeting.
Participants also raised and answered questions about the unique advantages of TCM in treating COVID-19, its clinical application and results and its role in global epidemic prevention and control.
Officials of the CAST Department of Academic and Societies Affairs also attended the meeting.
People.cn gave a live webcast of the event, which attracted 45,000 views online.
